Clinical Trial to Investigate Whether Hypertension Drug Ameliorates COVID-19 Severity

UC San Diego scientists have launched a clinical trial to investigate whether a drug approved for treating high blood pressure might also reduce the severity of COVID-19 infections, lowering rates for intensive care unit admissions, the use of mechanical ventilators and all-cause mortality.

Arthritis Drug Presents Promise as Treatment for COVID-19 Pneumonia

UC San Diego Health has launched a Phase III clinical trial to assess whether a medication used to treat rheumatoid might also have therapeutic value for patient with COVID-19 who have developed or are at high risk of developing serious lung damage from SARS-CoV-2 infections.

Baylor Scott & White Research Institute Exploring Potential Prevention Options, Therapies for COVID-19

Baylor Scott & White Research Institute, the research arm of Baylor Scott & White Health, is bringing clinical trials online at an unprecedented pace in response to COVID-19. A COVID-19 therapeutic task force of more than 20 multidisciplinary researchers positioned across the state of Texas has been putting their expertise in infectious disease, cardiology, immunology, molecular biology, and other specialties together to explore research opportunities for experimental prevention and treatment options and to develop investigator-initiated studies.

The Search for a Biological Link between Reactivated HSV and Neurological Disease

New research data in the journal PLoS Pathogens suggests that reactivated HSV in trigeminal nerves of laboratory mice kills off at least a portion of sensory neurons. The findings provide additional evidence that as humans get older, the long-term consequences of HSV infection in the nervous system can accumulate and cause neurological damage.

UAB experts involved with COVID-19 vaccine research available to comment on outbreak, what’s being reported, where concerns lie

Experts from the University of Alabama at Birmingham are avaliable to comment on the state of COVID-19, including the development of an investigational compound  at UAB, next steps for a vaccine, what the state of the outbreak looks like, what…

New Tool Monitors Real Time Mutations In Flu

A Rutgers-led team has developed a tool to monitor influenza A virus mutations in real time, which could help virologists learn how to stop viruses from replicating. The gold nanoparticle-based probe measures viral RNA in live influenza A cells, according to a study in The Journal of Physical Chemistry C. It is the first time in virology that experts have used imaging tools with gold nanoparticles to monitor mutations in influenza, with unparalleled sensitivity.

Communicating about coronavirus can be difficult

Communicating effectively during an outbreak can be tricky for government agencies charged with protecting the public, according to Glen Nowak, former director of media relations at the Centers for Disease Control and Prevention and professor of advertising and public relations at the University of Georgia’s Grady College of Journalism and Mass Communication.

Ohio State ethics and public health expert available to discuss coronavirus outbreak and the implications of quarantine, travel restrictions and other measures

COLUMBUS, Ohio – Amy Fairchild, ethicist, public health historian and dean of The Ohio State University College of Public Health, is available to discuss the ethical considerations and historical precedents of efforts to contain the coronavirus outbreak. Fairchild, who has…

What should health care professionals do to prepare for Coronavirus?

Tener Veenema, PhD, MPH, MS, RN, Internationally recognized expert in public health emergency preparedness. QUOTE: “Each day health care workers participate in disease surveillance, detection, and containment activities in order to protect their patients and their communities from the transmission…

Penn Study Paves Way for New Vaccines to Protect Infants Against Infections

A new Penn Medicine study puts researchers within closer reach of vaccines that can protect infants against infections by overcoming a mother’s antibodies, which are known to shut down immune defenses initiated by conventional vaccines. That hurdle largely explains why vaccinations for infectious diseases like influenza and measles not given until six to 12 months of age. Findings from the preclinical study were published online today in Science Translational Medicine.

Delivering TB Vaccine Intravenously Dramatically Improves Potency, Study Shows

Worldwide, more people die from tuberculosis than any other infectious disease, even though the vast majority were vaccinated. The vaccine just isn’t that reliable. But a new Nature study finds that simply changing the way the vaccine is administered could dramatically boost its protective power.

Modifier Gene May Explain Why Some with Cystic Fibrosis are Less Prone to Infection

People with cystic fibrosis who carry genetic variants that lower RNF5 gene expression have more mutant CFTR protein on cell surfaces. Even if the CFTR protein isn’t fully functional, it’s better than none, and may explain why some with cystic fibrosis are less prone to infection than others.

Wolters Kluwer Partners with Zhejiang University to Publish Infectious Microbes & Diseases Journal

Wolters Kluwer, Health announced today a partnership with Zhejiang University to publish the journal Infectious Microbes & Diseases (IMD) under the Lippincott portfolio to accelerate the dissemination, exchange and utilization of scientific research results related to the field of infectious microbes and infectious diseases. The open access journal provides a forum where researchers, clinicians and policymakers can exchange ideas and learn about significant advances in the field.

Mount Sinai Researchers Bring Us One Step Closer to Universal Influenza Vaccine

A team led by researchers at the Icahn School of Medicine at Mount Sinai is getting closer to a universal flu vaccine using a novel approach they’ve developed called chimeric hemagglutinin (cHA).

University of California, Irvine scientists available to speak about the impact of climate change on human health and wildfires

James Randerson, Chancellor’s Professor of Earth System Science at the University of California, Irvine, is a senior researcher on the impact of climate change on the ecology, particularly with regard to wildfires in important forest ecosystems. He was a senior…

Journal Supplement Provides Valuable Resource to Support Diversity in the Field of Infectious Diseases

A new collection of articles highlighting the science and complexity of inclusion, diversity, access, and equity is now available online, part of an ongoing commitment to drive improvements within the field of infectious diseases and the Infectious Diseases Society of America (IDSA). Published as a supplement to The Journal of Infectious Diseases (JID), the IDSA-sponsored collection includes articles written by both Society members and authors outside the field with deep knowledge and seasoned perspectives on these important issues.

Journal Supplement Provides Valuable Resource to Support Diversity in the Field of Infectious Diseases

A new collection of articles highlighting the science and complexity of inclusion, diversity, access, and equity is now available online, part of an ongoing commitment to drive improvements within the field of infectious diseases and the Infectious Diseases Society of America (IDSA). Published as a supplement to The Journal of Infectious Diseases (JID), the IDSA-sponsored collection includes articles written by both Society members and authors outside the field with deep knowledge and seasoned perspectives on these important issues.

Journal Supplement Provides Valuable Resource to Support Diversity in the Field of Infectious Diseases

A new collection of articles highlighting the science and complexity of inclusion, diversity, access, and equity is now available online, part of an ongoing commitment to drive improvements within the field of infectious diseases and the Infectious Diseases Society of America (IDSA). Published as a supplement to The Journal of Infectious Diseases (JID), the IDSA-sponsored collection includes articles written by both Society members and authors outside the field with deep knowledge and seasoned perspectives on these important issues.

Infectious Diseases Society of America (IDSA)

Public Comment Period for IDSA/AAN/ACR Draft Lyme Disease Guidelines Open Through Aug. 10

The Infectious Diseases Society of America (IDSA), the American Academy of Neurology (AAN), and the American College of Rheumatology (ACR) have opened a public comment period for the draft of their joint guidelines for the prevention, diagnosis, and treatment of Lyme disease.…